FDA finalizes guidance on dose optimization studies for cancer drugs
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyCBERCDERChemistry, Manufacturing and Controls (CMC)GuidancePatient-focused drug developmentPersonalized medicinePharmaceuticalsProject managementRegulatory Intelligence/PolicySubmission and registrationUnited States